HSHHSH Health Technology Supplier Hub

All suppliers

Showing 101–125 of 278

HeartFlowHQ United States · North America
Clinical AI & decision supportImaging, PACS & RIS

FY2025 revenue $176.0m (+40.0%); operating margin -36.4%; net loss $116.8m.

No debt; $280.2m cash.

Financial health: WeakRisk summary →
No reviews yet
View profile
Heidi HealthHQ Australia · Asia-Pacific
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Helium HealthHQ Nigeria · Middle East & Africa
Electronic health records (EHR/EPR)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Hippocratic AIHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
HologicHQ United States · North America
Diagnostics & IVDImaging, PACS & RIS

Listed (HOLX); FY2025 full-year figures not yet captured, so not assessed.

Agreed in Oct 2025 to be acquired by Blackstone and TPG funds (up to $79 a share).

Financial health: Not assessedRisk summary →
No reviews yet
View profile
HumaHQ United Kingdom · Europe
Digital therapeutics & appsRemote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Hyland HealthcareHQ United States · North America
Imaging, PACS & RISInteroperability & integration

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Ibex Medical AnalyticsHQ Israel · Middle East & Africa
Clinical AI & decision supportLaboratory & pathology (LIMS)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
IBMHQ United States · North America
Clinical AI & decision supportInfrastructure & cloud

FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.

Cash $14.50bn; debt $61.30bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
iCADHQ United States · North America
Clinical AI & decision supportImaging, PACS & RIS

Part of RadNet (RDNT).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
ICU MedicalHQ United States · North America
Medical devices & monitoring

FY2025 revenue $2.23bn (-6.3%); operating margin 1.9%; net income $0.7m.

Cash $308.0m; debt $1.28bn.

Financial health: FairRisk summary →
No reviews yet
View profile
Ieso Digital HealthHQ United Kingdom · Europe
Digital therapeutics & appsMental health, community & social care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
IlluminaHQ United States · North America
Genomics & precision medicine

FY2025 revenue $4.34bn (-0.7%); operating margin 18.6%; net income $850.0m.

Cash $1.63bn; debt $1.99bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
ImprivataHQ United States · North America
Cyber security

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
IMS MAXIMSHQ United Kingdom · Europe
Electronic health records (EHR/EPR)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InfermedicaHQ Poland · Europe
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InforHQ United States · North America
ERP, finance & supply chain

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InhealthcareHQ United Kingdom · Europe
Remote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InnovaccerHQ United States · North America
Interoperability & integrationPopulation health & analytics

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InovalonHQ United States · North America
Population health & analyticsRevenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InsuletHQ United States · North America
Medical devices & monitoring

FY2025 revenue $2.71bn (+30.7%); operating margin 17.5%; net income $247.1m.

Cash $716.1m; debt $949.2m.

Financial health: StrongRisk summary →
No reviews yet
View profile
InteleradHQ Canada · North America
Imaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
InterSystemsHQ United States · North America
Electronic health records (EHR/EPR)Interoperability & integrationPopulation health & analytics

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Intuitive SurgicalHQ United States · North America
Surgical & theatre systems

FY2025 revenue $10.06bn (+20.5%); operating margin 29.3%; net income $2.86bn.

No debt; $9.03bn cash and investments.

Financial health: StrongRisk summary →
No reviews yet
View profile